Product

IASOglio - Fluoroethyl-L tyrosine (¹⁸F)

Marketing Authorizations

Country
Product Name
MA number
Date of registration
PDF
France
IASOglio
34009 550 105 1 7 (15mL)/ 34009 550 105 2 4 (25 mL)
23.12.2015
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
No data was found
Poland
IASOglio
27420
24.10.2022
No data was found
No data was found
No data was found

IASOglio is indicated for use with positron emission tomography (PET).

IASOglio is used for imaging in patients undergoing oncologic diagnostic procedures describing functions or diseases where enhanced amino acid influx of specific organs or tissues is the diagnostic target.

The following indications have been particularly documented:

Gliomas

  • Characterisation of brain lesions suggestive of glioma
  • Selecting the best biopsy site in brain lesion suggestive of glioma
  • Non-invasive grading of glioma
  • Pre therapeutic delineation of viable glioma tissue
  • After treatment : detection of viable tumour tissue in case of suspicion of persistent or recurrent glioma

Therapeutic indications. This medicinal product is for diagnostic use only.

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Find out more about Curium’s global footprint

Scroll to Top
Iason Logo Alt
curium logo

Welcome to our new website

You've been redirected from iason.eu to our new domain curium-austria.com

Curium acquired IASON in June of 2021, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions. Learn more on Curium’s website